Výsledky vyhledávání - "Giuseppa Penna"

Akademický článek

Potential New Therapies 'ROS-Based' in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis

Autor: Raffaele Sciaccotta, Sebastiano Gangemi, Giuseppa Penna, Laura Giordano, Giovanni Pioggia, Alessandro Allegra

Publikováno v: Antioxidants, Vol 13, Iss 4, p 475 (2024)

Chronic lymphocytic leukemia, in spite of recent advancements, is still an incurable disease; the majority of patients eventually acquire resistance to treatment through relapses. In all subtypes of chronic lymphocytic leukemia, the disruption of nor

Externí odkaz: https://doaj.org/article/195ff18ddfcc40e887085403bef4af96

Zobrazit plný text záznamu

Akademický článek

Efficacy of nilotinib in a young patient with high Sokal risk CML Ph+ in treatment failure after high dose imatinib

Autor: Sabina Russo, Giuseppa Penna, Arianna D’Angelo, Alessandro Allegra, Andrea Alonci, Caterina Musolino

Publikováno v: Clinical Management Issues, Vol 5, Iss 5S, Pp 7-14 (2015)

This article describes the case of a 44 year old man, at high-risk according to the Sokal Index, after CML Ph+ diagnosis, started imatinib at the standard dose (400 mg/day). Initially he reached optimal response, but at month 12, because of a loss of

Externí odkaz: https://doaj.org/article/3f668b47cbcb49a38a9f7ff72e1b146e

Zobrazit plný text záznamu

Author response for 'Management of chronic lymphocytic leukemia in Italy during a one year of the COVID‐19 pandemic and at the start of the vaccination program. A Campus CLL report'

Autor: null Antonio Cuneo, null Gian Matteo Rigolin, null Marta Coscia, null Giulia Quaresmini, null Lydia Scarfò, null Francesca Romana Mauro, null Marina Motta, null Francesca Maria Quaglia, null Livio Trentin, null Andrea Ferrario, null Luca Laurenti, null Gianluigi Reda, null Angela Ferrari, null Daniela Pietrasanta, null Paolo Sportoletti, null Francesca Re, null Lorenzo De Paoli, null Myriam Foglietta, null Annamaria Giordano, null Monia Marchetti, null Lucia Farina, null Giovanni Del Poeta, null Marzia Varettoni, null Federico Chiurazzi, null Roberto Marasca, null Lara Malerba, null Adalberto Ibatici, null Maria Chiara Tisi, null Vittorio Stefoni, null Monica Leone, null Claudia Baratè, null Jacopo Olivieri, null Roberta Murru, null Massimo Gentile, null Alessandro Sanna, null Alessandro Gozzetti, null Valter Gattei, null Daniela Gottardi, null Enrico Derenzini, null Luciano Levato, null Lorella Orsucci, null Giuseppa Penna, null Annalisa Chiarenza, null Robin Foà

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::896c8128e164d867fd9169800e94b555
https://doi.org/10.1002/hon.2899/v2/response1

Zobrazit plný text záznamu

Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report

Publikováno v: Hematological Oncology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de954b5e8fac32cbb51a79af4a93065b
http://hdl.handle.net/11391/1495602

Zobrazit plný text záznamu

Vaccination of multiple myeloma: Current strategies and future prospects

Autor: Valerio Maisano, Alessandro Allegra, Caterina Musolino, Vanessa Innao, Giuseppa Penna, Bruna Greve, Sabina Russo

Publikováno v: Critical Reviews in Oncology/Hematology. 96:339-354

Tumor immunotherapy holds great promise in controlling multiple myeloma (MM) and may provide an alternative treatment modality to conventional chemotherapy for MM patients. For this reason, a major area of investigation is the development of cancer v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c04a9d9703ec309284cc40197acb3b
https://doi.org/10.1016/j.critrevonc.2015.06.003

Zobrazit plný text záznamu

Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients

Autor: Massimo Martino, Francesca Ronco, Caterina Musolino, Roberta Fedele, Caterina Alati, Fortunato Morabito, Giuseppa Penna, Tiziana Moscato, Santo Neri, Massimo Gentile, Eugenio Piro, Iolanda Vincelli, Anna Grazia Recchia, Stefano Molica

Publikováno v: Cytotherapy. 17:1485-1493

Background aims Filgrastim and lenograstim are the standard granulocyte colony-stimulating factor (G-CSF) agents for peripheral blood stem cell mobilization (PBSC) in patients who undergo autologous stem cell transplantation. Methods To assess whethe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02262169c1bb2cc75923c41f96935b4d
https://doi.org/10.1016/j.jcyt.2015.05.010

Zobrazit plný text záznamu

Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options

Autor: Sabina Russo, Arianna D'Angelo, Bruna Greve, Sara Catena, Alessandro Allegra, Caterina Musolino, Giuseppa Penna, Andrea Alonci, Demetrio Gerace

Publikováno v: Hematological Oncology. 30:41-45

Stevens- Johnson syndrome (SJS) is a severe and life-threatening condition. Although allopurinol, an antihyperuricemia drug, is the drug most commonly associated with SJS, more than 100 different causative drugs have been reported. Among hematologic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4e99fdafb2f8a916ee8618e0142a9d0b
https://doi.org/10.1002/hon.1000

Zobrazit plný text záznamu

Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors

Autor: Caterina Musolino, Emanuela Sant’Antonio, Alessandro Allegra, Antonino Cannavò, Giuseppa Penna, Demetrio Gerace, Arianna D'Angelo, Sabina Russo, Andrea Alonci

Publikováno v: European Journal of Haematology. 86:93-110

Despite advances in understanding the molecular pathogenesis of multiple myeloma and promising new therapies, almost all patients eventually relapse with resistant disease. There is therefore a strong rationale for combining novel therapies that targ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3a4e591fa07da70c55da70f42c536f9e
https://doi.org/10.1111/j.1600-0609.2010.01558.x

Zobrazit plný text záznamu

Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera

Autor: Alessandro Allegra, Giuseppa Penna, Sabina Russo, Andrea Alonci, Antonino Cannavò, Salvatore Campo, Demetrio Gerace, Caterina Musolino, Giacomo Bellomo, Raffaella Centorrino, Annamaria Petrungaro

Publikováno v: Leukemia & Lymphoma. 52:101-107

Neutrophil gelatinaase-associated lipocalin (NGAL) is a glycoprotein bound with matrix metalloproteinase-9 (MMP-9) in human neutrophils, and elevated tissue NGAL expression has been documented in different infectious and inflammatory conditions. Rece

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be919c580545f22be20dbdc671229be
https://doi.org/10.3109/10428194.2010.531413

Zobrazit plný text záznamu

Cardiac Involvement in Patients with Hematologic Malignancies

Autor: Andrea Alonci, Antonino Cannavò, Arianna D'Angelo, Caterina Musolino, Giuseppa Penna, Giacomo Bellomo, Sabina Russo, Alessandro Allegra

Publikováno v: Journal of Investigative Medicine. 58:859-874

Authors have reviewed literature about the management of patients with cardiologic disease occurring secondary to hematologic pathology itself or its therapy, with a focus on infiltration of myocardium in acute and chronic leukemia, lymphoma, multipl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::866e19d502bc09d1089d7cd350df1396
https://doi.org/10.2310/jim.0b013e3181efbc4e

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání